Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EMR
EMR logo

EMR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
148.500
Open
147.060
VWAP
145.82
Vol
788.60K
Mkt Cap
82.48B
Low
144.305
Amount
114.99M
EV/EBITDA(TTM)
18.03
Total Shares
562.00M
EV
94.16B
EV/OCF(TTM)
31.10
P/S(TTM)
4.56
Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
Show More

Events Timeline

(ET)
2026-04-02
09:10:00
Emerson Selected to Automate $2B Louisiana Green Fuels Project
select
2026-03-04 (ET)
2026-03-04
13:50:00
Former OpenAI Chief Research Officer Raises $70M for New Startup
select
link

News

PRnewswire
9.5
04-14PRnewswire
Emerson to Report Q2 Results on May 5, 2026
  • Earnings Release Schedule: Emerson is set to release its second-quarter financial results after market close on May 5, 2026, which is expected to significantly impact investor sentiment.
  • Investor Conference Call: On the same day, Emerson's senior management will hold a conference call at 4:30 p.m. Eastern Time to discuss the results, providing in-depth analysis and future outlook.
  • Online Participation: Interested parties can register through Emerson's Investor Relations website to listen to the call and view presentation slides posted in advance, enhancing transparency and accessibility.
  • Disclosure Channels: Emerson uses its Investor Relations website as a primary means of disclosing material information to investors, ensuring compliance with regulatory obligations and keeping stakeholders informed.
Fool
8.5
04-10Fool
Investment Outlook for Honeywell and Emerson
  • Dividend Appeal: Emerson Electric has raised its dividend for 69 consecutive years, making it one of the Dividend Kings, while Honeywell has increased its payout for 15 years, offering yields of 1.50% and 2% respectively, attracting income-seeking investors.
  • Transformation Strategy: Honeywell is undergoing a significant transformation, planning to spin off its aerospace division in Q3, with analysts suggesting this move could unlock 'sum-of-the-parts' value for investors, allowing a sharper focus on industrial automation.
  • Market Positioning: Emerson's transformation is largely complete, focusing on industrial automation and intelligent devices to help factories and power plants automate operations, appealing to conservative investors, while Honeywell is still in transition, suitable for those optimistic about its future potential.
  • Valuation Comparison: Both companies share similar valuations on a forward earnings basis, so investors should choose based on personal investment goals, with Emerson being ideal for those seeking reliable income and Honeywell for those betting on its spinoff unlocking hidden value.
NASDAQ.COM
7.5
04-10NASDAQ.COM
Industrial Companies Transforming for Dividend Appeal
  • Dividend Appeal: Honeywell and Emerson Electric, as leaders in industrial automation, provide steady cash flow and reliable dividends, with Honeywell offering a 2% yield and Emerson increasing dividends for 69 consecutive years, attracting income-seeking investors.
  • Business Transformation: Honeywell is transforming into a software-integrated industrial giant, planning to spin off its aerospace division in Q3, a move analysts believe could unlock 'sum-of-the-parts' value for investors and enhance competitiveness in high-growth sectors.
  • Market Environment: Amid the Dow Jones Industrial Average entering correction territory, companies with physical assets and essential infrastructure stand out for their pricing power and steady cash flow, with Honeywell and Emerson exemplifying this trend.
  • Investment Choices: Emerson's transformation is largely complete, making it a pure play on the fourth industrial revolution and appealing to conservative investors, while Honeywell is still in transition, suitable for those optimistic about its future potential.
Globenewswire
2.0
04-09Globenewswire
Pharmaceutical Industry Accelerates AI Compliance Transformation
  • AI-Driven Compliance Monitoring: Pharmaceutical manufacturers are shifting towards AI-driven real-time monitoring systems that dynamically assess compliance throughout the production process, thereby reducing human error and enhancing data integrity to meet increasingly stringent regulatory demands.
  • FDA Support for New Technologies: The U.S. FDA encourages the adoption of advanced manufacturing technologies and continuous production models, which is driving the pharmaceutical industry towards intelligent, automated compliance infrastructures, reducing the risk of manufacturing failures and supply disruptions.
  • Rise of Pharma 4.0: The emergence of the Pharma 4.0 concept signifies a significant evolution in pharmaceutical development and manufacturing, integrating AI, robotics, and advanced analytics to enhance productivity and product quality while promoting data-driven decision-making.
  • Significant Market Potential: The global pharmaceutical manufacturing market is expected to reach $1 trillion, with investments increasingly directed towards automation and digital infrastructure, indicating a strategic shift in companies' focus towards compliance and efficiency.
Newsfilter
7.5
04-09Newsfilter
Pharmaceutical Industry Shifts to AI-Driven Compliance
  • AI-Driven Compliance Transformation: Pharmaceutical manufacturers are increasingly integrating artificial intelligence into production workflows for real-time compliance monitoring, replacing traditional manual checks and retrospective audits, thereby enhancing production efficiency and reducing human error risks.
  • FDA Support for New Technologies: The U.S. Food and Drug Administration (FDA) is promoting the adoption of advanced manufacturing technologies, encouraging companies to implement real-time data monitoring to ensure product quality and minimize manufacturing failure risks, which introduces new compliance standards for the industry.
  • Rise of Pharma 4.0: The emergence of the Pharma 4.0 concept signifies a significant transformation in the pharmaceutical industry, integrating artificial intelligence, robotics, and data analytics to enhance production efficiency and product quality while driving data-driven decision-making processes.
  • Significant Market Potential: The global pharmaceutical manufacturing market is projected to reach $1 trillion, with increasing investments in automation and digital infrastructure, indicating the industry's focus on intelligent manufacturing and compliance will drive sustainable growth.
PRnewswire
7.5
04-02PRnewswire
Emerson Supports First Biomass Carbon Capture Facility
  • Project Scale and Investment: Strategic Biofuels is investing $2 billion in its Louisiana Green Fuels facility, which will convert 1.3 million tons of forestry residuals into renewable power annually, demonstrating a strong commitment to sustainable energy.
  • Carbon Capture Capacity: The facility will capture and permanently store 1.1 million metric tons of CO₂ each year in secure geological formations nearly a mile underground, positioning Louisiana as a leader in carbon-neutral energy production.
  • Automation Technology Application: Emerson will deploy its DeltaV™ Automation Platform along with a suite of advanced automation and measurement technologies to optimize the plant's integrated operations, ensuring timely project completion and enhanced operational efficiency.
  • Sustainability Strategy: Emerson's Chief Sustainability Officer highlighted that the project will not only convert waste biomass into reliable power but also permanently remove carbon from the atmosphere through carbon capture technology, driving the future of clean energy.
Wall Street analysts forecast EMR stock price to rise
14 Analyst Rating
Wall Street analysts forecast EMR stock price to rise
7 Buy
6 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
125.00
Averages
150.46
High
170.00
Current: 0.000
sliders
Low
125.00
Averages
150.46
High
170.00
Barclays
Equal Weight
downgrade
$145 -> $140
AI Analysis
2026-04-01
Reason
Barclays
Price Target
$145 -> $140
AI Analysis
2026-04-01
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on Emerson to $140 from $145 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the multi-industry group as part of a Q1 earnings preview. The sector faces "more demand question marks" but expectations are "somewhat re-based," the analyst tells investors in a research note.
Wells Fargo
Joseph O'Dea
Equal Weight
downgrade
$160 -> $135
2026-04-01
Reason
Wells Fargo
Joseph O'Dea
Price Target
$160 -> $135
2026-04-01
downgrade
Equal Weight
Reason
Wells Fargo analyst Joseph O'Dea lowered the firm's price target on Emerson to $135 from $160 and keeps an Equal Weight rating on the shares. The Middle East conflict didn't drive an elevated level of caution in most of the firm's catch-up calls. But just like tariffs sidelined a PMI recovery last year, Wells is cautious that a new source of uncertainty dampens sentiment until there's better clarity.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EMR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Emerson Electric Co (EMR.N) is 22.42, compared to its 5-year average forward P/E of 19.48. For a more detailed relative valuation and DCF analysis to assess Emerson Electric Co's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
19.48
Current PE
22.42
Overvalued PE
21.62
Undervalued PE
17.34

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
14.89
Current EV/EBITDA
14.76
Overvalued EV/EBITDA
16.97
Undervalued EV/EBITDA
12.82

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.32
Current PS
4.13
Overvalued PS
3.82
Undervalued PS
2.83

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Focus on stocks in the prompt
Intellectia · 165 candidates
Market Cap: >= 1000.00MMoving Average Relationship: PriceAboveMA20Quarter Eps Qoq Growth: >= 5.0%Quarter Revenue Qoq Growth: >= 5.0%
Ticker
Name
Market Cap$
top bottom
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PG logo
PG
Procter & Gamble Co
341.30B
CVX logo
CVX
Chevron Corp
335.71B
PM logo
PM
Philip Morris International Inc
262.78B
PEP logo
PEP
PepsiCo Inc
200.64B
TXN logo
TXN
Texas Instruments Inc
176.65B

Whales Holding EMR

B
Bank J. Safra Sarasin AG
Holding
EMR
+76.66%
3M Return
S
Schroder Investment Management Limited
Holding
EMR
+58.82%
3M Return
W
Wilson Asset Management (International) Pty Ltd.
Holding
EMR
+26.56%
3M Return
S
Schonfeld Strategic Advisors LLC
Holding
EMR
+21.49%
3M Return
Q
Quilter Cheviot Limited
Holding
EMR
+14.12%
3M Return
B
BNY Mellon Advisors, Inc.
Holding
EMR
+11.65%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Emerson Electric Co (EMR) stock price today?

The current price of EMR is 144.65 USD — it has decreased -1.44

What is Emerson Electric Co (EMR)'s business?

Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.

What is the price predicton of EMR Stock?

Wall Street analysts forecast EMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is150.46 USD with a low forecast of 125.00 USD and a high forecast of 170.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Emerson Electric Co (EMR)'s revenue for the last quarter?

Emerson Electric Co revenue for the last quarter amounts to 4.35B USD, increased 4.10

What is Emerson Electric Co (EMR)'s earnings per share (EPS) for the last quarter?

Emerson Electric Co. EPS for the last quarter amounts to 1.07 USD, increased 4.90

How many employees does Emerson Electric Co (EMR). have?

Emerson Electric Co (EMR) has 71000 emplpoyees as of April 21 2026.

What is Emerson Electric Co (EMR) market cap?

Today EMR has the market capitalization of 82.48B USD.